Strengthening Sanctions on Fentanyl Traffickers Act of 2025

Summary

Creates new, broad U.S. sanctions authorities to target foreign persons, companies, ports, and online marketplaces tied to the production, shipment, or enabling of illicit synthetic narcotics (including fentanyl) and their chemical precursors, with a focus on persons and entities connected to the People’s Republic of China. It also keeps existing Kingpin Act sanctions on seven Mexican transnational criminal organizations in place and sets rules for reporting, certification, termination, and limited exceptions for lawful intelligence, law enforcement, and trade in goods. The law defines key terms, requires the President to prioritize identifying PRC-linked actors in shipments that help produce fentanyl trafficked into the United States, authorizes IEEPA blocking sanctions (after 180 days) and a broader menu of penalties, and sets expiration, waiver, and congressional reporting requirements for those sanctions.

• Creates new statutory authority to impose IEEPA blocking sanctions on PRC-linked persons and entities involved in producing, shipping, or facilitating illicit synthetic narcotics and precursors.
• Directs the President to prioritize identifying PRC citizens and PRC-organized entities involved in shipments used to make fentanyl trafficked into the U.S., until certified otherwise to Congress.
• Maintains existing Kingpin Act sanctions on seven major Mexican transnational criminal organizations and requires congressional notice before those sanctions can be ended.
• Authorizes a broad menu of sanctions (banking, investment, procurement, visa limits, Federal Reserve restrictions) against foreign persons tied to international narcotics trafficking or who benefit from it.
• IEEPA blocking authority for PRC-specific designations becomes available 180 days after enactment; broader sanctions typically expire after six years unless extended for national security reasons.
• Includes exceptions for lawful imports (excluding technical data) and authorized U.S. intelligence or law enforcement activities.
• Provides congressional oversight routes: committees can request determinations and the President must report actions or planned sanctions within 120 days.
• Expands definitions of covered chemicals, active pharmaceutical ingredients, and means of production to clarify enforcement reach.
• Applies extraterritorial pressure on financial institutions, ports, logistics providers, online marketplaces, and entities operating under PRC jurisdiction.
• Creates criminal and civil liability exposure under existing IEEPA penalty provisions for violations.